Early Surgical Intervention to Treat Epilepsy
NCT00040326 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 200
Last updated 2010-02-23
Summary
The purpose of this trial is to compare the effectiveness of early surgical intervention for mesial temporal lobe epilepsy to continued treatment with antiepileptic drugs.
Conditions
Interventions
- PROCEDURE
-
anteromesial temporal resection
surgical treatment for epilepsy
- DRUG
-
antiepileptic drugs
pharmacotherapy
Sponsors & Collaborators
-
University of California, Los Angeles
lead OTHER
Principal Investigators
-
Jerome Engel, Jr., M.D., Ph.D. · UCLA School of Medicine, Department of Neurology
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- DOUBLE
- Model
- PARALLEL
Eligibility
- Min Age
- 12 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2002-07-31
- Primary Completion
- 2007-11-30
- Completion
- 2007-11-30
Countries
- United States
Study Locations
More Related Trials
-
Study of Specimens Obtained During Epilepsy Surgery
NCT00025714 ·Status: COMPLETED
-
Retigabine (Adjunctive Therapy) Efficacy and Safety Study for Partial Onset Refractory Seizures in Epilepsy
NCT00232596 ·Status: COMPLETED ·Phase: PHASE3
-
Treatment Of Primary Generalized Tonic-Clonic Seizures With An Investigational New Drug
NCT00043901 ·Status: COMPLETED ·Phase: PHASE4
-
A Study of the Efficacy and Safety of RWJ-333369 as add-on Therapy in the Treatment of Partial Onset Seizures.
NCT00425282 ·Status: COMPLETED ·Phase: PHASE3
-
Study of Retigabine Immediate Release as Adjunctive Therapy to Specified Monotherapy Antiepileptic Treatments in Adults With Partial-Onset Seizures
NCT01227902 ·Status: COMPLETED ·Phase: PHASE3
-
Seizure Prophylaxis in Patients With Glioma or Brain Metastasis
NCT03436433 ·Status: TERMINATED ·Phase: PHASE2
-
Cortical Resections in Drug Resistant Epilepsy
NCT04553354 ·Status: UNKNOWN
-
Duration of Anti-convulsant Therapy for Acute Symptomatic Seizure in Acute Encephalitis Syndrome
NCT03181945 ·Status: UNKNOWN ·Phase: NA
-
Investigating Epilepsy: Screening and Evaluation
NCT03478852 ·Status: RECRUITING
-
Efficacy of BGG492 in Individuals With Refractory Partial Seizures Undergoing Inpatient Evaluation for Epilepsy Surgery
NCT00887861 ·Status: COMPLETED ·Phase: PHASE2
-
Tumor Related Epilepsy
NCT02639325 ·Status: RECRUITING
-
Cardiovascular Risk Reduction in Epilepsy
NCT05704439 ·Status: WITHDRAWN ·Phase: NA
-
A Study of GWP42006 in People With Focal Seizures - Part B
NCT02365610 ·Status: COMPLETED ·Phase: PHASE2
-
An Open-Label Extension Study to Evaluate the Safety and Effectiveness of RWJ 333369 in Patients With Epilepsy
NCT00210652 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Investigate Dosage, Effectiveness, and Safety of Perampanel When Used as First Add-on Therapy in Participants >=12 Years With Partial Onset Seizures With or Without Secondary Generalization or With Primary Generalized Tonic-Clonic Seizures Associated With Idiopathic Generalized Epilepsy
NCT04252846 ·Status: COMPLETED
-
Safety, Tolerability, and Exploratory Efficacy of Adjunctive EQU-001 for Seizures in Adults With Epilepsy
NCT05063877 ·Status: UNKNOWN ·Phase: PHASE2
-
Efficacy and Safety of BGG492 as Adjunctive Treatment in Patients With Partial Onset Seizures
NCT01147003 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of the Effectiveness, Safety, and Tolerability of Carisbamate as Add-On Therapy in Patients With Partial Onset Seizures.
NCT00740623 ·Status: COMPLETED ·Phase: PHASE3
-
Pathophysiology Based Therapy of Early Onset Epileptic Encephalopathies
NCT02968966 ·Status: WITHDRAWN ·Phase: PHASE2
-
Evaluation and Treatment of Patients With Epilepsy
NCT00013845 ·Status: TERMINATED
-
A Study of GWP42006 in People With Focal Seizures - Part A
NCT02369471 ·Status: COMPLETED ·Phase: PHASE2
-
An Open-Label Extension Study of the Effectiveness and Safety of the Investigational Compound RWJ-333369 in Patients With Epilepsy
NCT00210522 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Evaluate the Efficacy and Safety of Seletracetam in Adult Patients With Refractory Partial Onset Seizures
NCT00422110 ·Status: WITHDRAWN ·Phase: PHASE2/PHASE3
-
Study to Evaluate the Safety and Effectiveness of USL255 in Patients With Refractory Partial-onset Seizures
NCT01142193 ·Status: COMPLETED ·Phase: PHASE3
-
Role of Hormones in Susceptibility to Seizures in Women With Epilepsy
NCT00044252 ·Status: COMPLETED